Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

194.21 +0.19 (+0.10%)
Official Closing Price Updated: 4:10 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,695,983
Open 193.86
Bid (Size) 192.61 (1)
Ask (Size) 194.48 (1)
Prev. Close 194.02
Today's Range 191.81 - 194.59
52wk Range 135.85 - 199.95
Shares Outstanding N/A
Dividend Yield 3.05%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Time To Invest And Or Trade In Bio-Tech Stocks?
Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help... 
Via Talk Markets
Topics ETFs
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
The stock has been a winner, but there may be better times ahead for buying. 
Via The Motley Fool
Topics Stocks
Exposures US Equities

Performance

YTD
+21.52%
+21.52%
1 Month
+1.56%
+1.56%
3 Month
+16.60%
+16.60%
6 Month
+7.18%
+7.18%
1 Year
+28.48%
+28.48%

More News

Read More
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Via Benzinga
What the Options Market Tells Us About AbbVie
Via Benzinga
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Via Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Via Benzinga
Peering Into AbbVie's Recent Short Interest
Via Benzinga
3 Things You Need to Know if You Buy AbbVie Stock Today
Via The Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
Via The Motley Fool
Earn $1,000 Per Month in Dividends From These 4 Stocks
Via The Motley Fool
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
Via Benzinga
AbbVie Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
AbbVie Stock Post Humira is Still an Attractive Stock to Hold
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
Via FinancialNewsMedia
Exposures COVID-19
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
From FN Media Group LLC
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Dividend Stocks You Can Safely Hold Through a Recession
Via The Motley Fool
2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer
Via The Motley Fool
Stock Market Rally Mixed; Dow Jones Hits High While Nvidia Tumbles On Earnings: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
Via The Motley Fool
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
Via The Motley Fool
2 Incredibly Cheap Healthcare Stocks to Buy Now
Via The Motley Fool
Biotech And Life Science Sector Update Summer Of 2024
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.